Pendal Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,914
| Closed | -$3.72M | – | 493 |
|
|
2022
Q3 | $3.72M | Buy |
13,914
+9,429
| +210% | +$2.52M | 0.04% | 158 |
|
|
2022
Q2 | $915K | Sell |
4,485
-2,668
| -37% | -$544K | 0.01% | 286 |
|
|
2022
Q1 | $1.51M | Buy |
7,153
+4,111
| +135% | +$866K | 0.01% | 295 |
|
|
2021
Q4 | $730K | Buy |
3,042
+1,608
| +112% | +$386K | 0.01% | 380 |
|
|
2021
Q3 | $406K | Sell |
1,434
-104
| -7% | -$29.4K | ﹤0.01% | 438 |
|
|
2021
Q2 | $533K | Sell |
1,538
-11,805
| -88% | -$4.09M | ﹤0.01% | 406 |
|
|
2021
Q1 | $3.73M | Buy |
13,343
+446
| +3% | +$125K | 0.04% | 164 |
|
|
2020
Q4 | $3.16M | Sell |
12,897
-14,116
| -52% | -$3.46M | 0.03% | 157 |
|
|
2020
Q3 | $7.66M | Sell |
27,013
-8,025
| -23% | -$2.28M | 0.09% | 85 |
|
|
2020
Q2 | $9.38M | Buy |
35,038
+12,780
| +57% | +$3.42M | 0.13% | 73 |
|
|
2020
Q1 | $7.04M | Sell |
22,258
-25,873
| -54% | -$8.19M | 0.12% | 74 |
|
|
2019
Q4 | $14.3M | Sell |
48,131
-25,729
| -35% | -$7.63M | 0.19% | 63 |
|
|
2019
Q3 | $17.2M | Sell |
73,860
-25,718
| -26% | -$5.99M | 0.22% | 55 |
|
|
2019
Q2 | $23.3M | Buy |
99,578
+2,105
| +2% | +$492K | 0.32% | 51 |
|
|
2019
Q1 | $23M | Buy |
97,473
+40,443
| +71% | +$9.56M | 0.32% | 53 |
|
|
2018
Q4 | $17.2M | Sell |
57,030
-10,282
| -15% | -$3.09M | 0.27% | 63 |
|
|
2018
Q3 | $23.8M | Buy |
67,312
+20,513
| +44% | +$7.25M | 0.32% | 56 |
|
|
2018
Q2 | $13.6M | Buy |
46,799
+2,273
| +5% | +$660K | 0.18% | 88 |
|
|
2018
Q1 | $12.2M | Sell |
44,526
-2,032
| -4% | -$556K | 0.16% | 91 |
|
|
2017
Q4 | $14.8M | Buy |
46,558
+4,520
| +11% | +$1.44M | 0.19% | 87 |
|
|
2017
Q3 | $13.2M | Sell |
42,038
-1,372
| -3% | -$431K | 0.17% | 97 |
|
|
2017
Q2 | $11.8M | Buy |
+43,410
| New | +$11.8M | 0.17% | 99 |
|